GSK sues Glenmark over US Malarone patents
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline has filed a suit against Glenmark Generics in the US District Court for the District of Delaware, alleging patent infringement related to Glenmark's generic version of the malaria treatment Malarone (atovaquone plus proguanil HCl).